According to Benitec Biopharma latest financial reports the cash on hand of BNTC is $2.48M, an decrease of -39.02% to 2022. At the end of 2022 company had $4.06M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $2.48M | -39.02% |
2022 | $4.06M | -79.45% |
2021 | $19.77M | 101.70% |
2020 | $9.80M | -6.55% |
2019 | $10.49M | - |